Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

The 2024 consensus emphasizes tailored assessment of older adults with prostate cancer, balancing life expectancy, comorbidities, and goals of care across localized and advanced disease.

What this guide covers: Understanding · Comprehensive · Localized · Advanced · Shared

Understanding

Prostate Cancer in Older Adults Prostate cancer mainly affects older men, with risk rising sharply with age. Most deaths occur in men over 70. Family history matters for younger patients.

Comprehensive

Health Assessment Before treatment, clinicians should assess overall health, frailty, and life expectancy rather than age alone. Comorbidities guide the intensity of therapy.

Localized

Disease Management For localized cancer, options range from active surveillance to surgery or radiation. The chosen approach depends on tumor risk and the patient's functional status.

Advanced

Disease and Supportive Care Advanced prostate cancer often needs hormone therapy and systemic treatment. Supportive care addresses symptoms, bone health, and quality of life throughout the journey.

Shared

Decision Making Treatment plans should reflect patient values and goals. Open discussion between family, patient, and care team improves outcomes and satisfaction.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.